2014
Lessons learned from extracorporeal membrane oxygenation as a bridge to lung transplantation
Shumaster V, Jawitz O, Yuh D, Bonde P. Lessons learned from extracorporeal membrane oxygenation as a bridge to lung transplantation. ScienceOpen Research 2014, 0 DOI: 10.14293/a2199-1006.01.sor-med.bg1r6.v1.Peer-Reviewed Original ResearchExtracorporeal membrane oxygenationLung transplantationECMO groupPostoperative complicationsMembrane oxygenationUse of ECMOSurvival rateOutcomes of patientsFrequent postoperative complicationOrgan Sharing databaseCareful patient selectionAirway dehiscenceRejection episodesECMO supportHospital stayLung transplantUNOS databasePulmonary embolismWorse survivalSharing databasePatient selectionUnited NetworkTransplantationControl groupComplicationsLessons learned from extracorporeal membrane oxygenation as a bridge to lung transplantation
Shumaster V, Jawitz O, Yuh D, Bonde P. Lessons learned from extracorporeal membrane oxygenation as a bridge to lung transplantation. ScienceOpen Research 2014 DOI: 10.14293/s2199-1006.1.sor-med.abg1r6.v1.Peer-Reviewed Original ResearchExtracorporeal membrane oxygenationLung transplantationECMO groupPostoperative complicationsMembrane oxygenationUse of ECMOSurvival rateOutcomes of patientsFrequent postoperative complicationOrgan Sharing databaseCareful patient selectionAirway dehiscenceRejection episodesECMO supportHospital stayLung transplantUNOS databasePulmonary embolismWorse survivalSharing databasePatient selectionUnited NetworkTransplantationControl groupComplications
2011
87 The Impact of Pre-Formed Donor-Specific HLA Antibodies on Early Clinical Outcomes in Lung Transplant Recipients
Fujimoto K, Shigemura N, Sareyyupoglu B, Bansal A, Minakata K, Shayan H, Ota T, Bhama J, Bonde P, Thacker J, Bermudez C, Zaldonis D, Zeevi A, Toyoda Y. 87 The Impact of Pre-Formed Donor-Specific HLA Antibodies on Early Clinical Outcomes in Lung Transplant Recipients. The Journal Of Heart And Lung Transplantation 2011, 30: s37. DOI: 10.1016/j.healun.2011.01.094.Peer-Reviewed Original ResearchPrimary graft dysfunctionMean fluorescent intensityAcute cellular rejectionEarly clinical outcomesClinical outcomesDSA groupDonor selectionSurvival rateDonor-specific HLA antibodiesClass II DSALung transplant recipientsPrimary graft failureLung transplant candidatesHLA-specific antibodiesLevels of AbsCellular rejectionGraft dysfunctionLTx candidatesLTx groupProspective crossmatchHLA antibodiesLung transplantTransplant recipientsDepletion therapyGraft failure